38 related articles for article (PubMed ID: 25488863)
1. Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients.
Zhang Q; Zhu L; Zhang J
BMC Cancer; 2015 Mar; 15():88. PubMed ID: 25886585
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.
Paik PK; Shen R; Won H; Rekhtman N; Wang L; Sima CS; Arora A; Seshan V; Ladanyi M; Berger MF; Kris MG
Cancer Discov; 2015 Jun; 5(6):610-21. PubMed ID: 25929848
[TBL] [Abstract][Full Text] [Related]
3. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Rekhtman N; Tafe LJ; Chaft JE; Wang L; Arcila ME; Colanta A; Moreira AL; Zakowski MF; Travis WD; Sima CS; Kris MG; Ladanyi M
Mod Pathol; 2013 Apr; 26(4):511-22. PubMed ID: 23196793
[TBL] [Abstract][Full Text] [Related]
4. Tongue carcinoma infrequently harbor common actionable genetic alterations.
Tan DS; Wang W; Leong HS; Sew PH; Lau DP; Chong FT; Krisna SS; Lim TK; Iyer NG
BMC Cancer; 2014 Sep; 14():679. PubMed ID: 25234657
[TBL] [Abstract][Full Text] [Related]
5. DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.
Wu Q; Luo X; Terp MG; Li Q; Li Y; Shen L; Chen Y; Jacobsen K; Bivona TG; Chen H; Zeng R; Ditzel HJ
Mol Cancer; 2021 Aug; 20(1):108. PubMed ID: 34446021
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors.
Izumi M; Oyanagi J; Sawa K; Fukui M; Ogawa K; Matsumoto Y; Tani Y; Suzumura T; Watanabe T; Kaneda H; Mitsuoka S; Asai K; Ohsawa M; Yamamoto N; Koh Y; Kawaguchi T
Sci Rep; 2021 Mar; 11(1):5680. PubMed ID: 33707471
[TBL] [Abstract][Full Text] [Related]
8. Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Friedlaender A; Banna G; Malapelle U; Pisapia P; Addeo A
Front Oncol; 2019; 9():166. PubMed ID: 30941314
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers.
Pickering CR; Zhang J; Neskey DM; Zhao M; Jasser SA; Wang J; Ward A; Tsai CJ; Ortega Alves MV; Zhou JH; Drummond J; El-Naggar AK; Gibbs R; Weinstein JN; Wheeler DA; Wang J; Frederick MJ; Myers JN
Clin Cancer Res; 2014 Jul; 20(14):3842-8. PubMed ID: 24874835
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer in Asian Indian females: Identification of disease-specific characteristics and outcome measures over a 12-year period.
Iyer H; Ghosh T; Garg A; Agarwal H; Jain D; Pandey R; Bhalla AS; Kumar R; Vashistha V; Tiwari P; Mittal S; Hadda V; Madan K; Guleria R; Mohan A
Lung India; 2023; 40(1):4-11. PubMed ID: 36695252
[TBL] [Abstract][Full Text] [Related]
11. Relevance of genetic alterations in squamous and small cell lung cancer.
Sabari JK; Paik PK
Ann Transl Med; 2017 Sep; 5(18):373. PubMed ID: 29057233
[TBL] [Abstract][Full Text] [Related]
12. Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey.
Bertaglia V; Vallone S; Pacchiana MV; Novello S
Lung Cancer Manag; 2017 Dec; 6(3):93-107. PubMed ID: 30643575
[TBL] [Abstract][Full Text] [Related]
13. High-resolution genomic configuration of
Hong SH; Kim TM
Transl Lung Cancer Res; 2024 Feb; 13(2):236-239. PubMed ID: 38496689
[No Abstract] [Full Text] [Related]
14. Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series.
Magnini D; Bria E; Cancellieri A; Livi V; Leoncini F; Ferrari M; Bruni T; Paioli D; Trisolini R
Monaldi Arch Chest Dis; 2023 Oct; ():. PubMed ID: 37789749
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK.
Rothschild SI
Cancers (Basel); 2015 May; 7(2):930-49. PubMed ID: 26018876
[TBL] [Abstract][Full Text] [Related]
16. Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.
Califano R; Abidin A; Tariq NU; Economopoulou P; Metro G; Mountzios G
Cancer Treat Rev; 2015 May; 41(5):401-11. PubMed ID: 25842168
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.
Sholl LM; Aisner DL; Varella-Garcia M; Berry LD; Dias-Santagata D; Wistuba II; Chen H; Fujimoto J; Kugler K; Franklin WA; Iafrate AJ; Ladanyi M; Kris MG; Johnson BE; Bunn PA; Minna JD; Kwiatkowski DJ;
J Thorac Oncol; 2015 May; 10(5):768-777. PubMed ID: 25738220
[TBL] [Abstract][Full Text] [Related]
18. Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung.
Qiong Z; Na WY; Bo W; Zhu Z; Ling P; Bo MH; Min TY; Lei Z; Na HD; Bo Z; Fang LJ; Seng ZS
Lung Cancer; 2015 Feb; 87(2):117-21. PubMed ID: 25488863
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
